Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$0.02.
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) rose 9047.62% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.25, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9733.76% up from last year.
- Per Fennec Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.02 for Q3 2025, which was up 9047.62% from -$0.11 recorded in Q2 2025.
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.41 during Q1 2024, with a 5-year trough of -$0.4 in Q4 2022.
- In the last 5 years, Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.16 in 2021 and averaged -$0.13.
- The largest annual percentage gain for Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) in the last 5 years was 27826.09% (2024), contrasted with its biggest fall of 20000.0% (2024).
- Fennec Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.16 in 2021, then plummeted by 150.0% to -$0.4 in 2022, then soared by 75.0% to -$0.1 in 2023, then skyrocketed by 45.01% to -$0.05 in 2024, then soared by 63.63% to -$0.02 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.02 for Q3 2025, versus -$0.11 for Q2 2025 and -$0.04 for Q1 2025.